Birch Allergy Market was valued at USD 1.45 billion in 2024 and is projected to reach ~USD 2.62 billion by 2034, growing at a CAGR of around 6.1%

The Birch Allergy Market was valued at USD 1.45 billion in 2024 and is projected to reach ~USD 2.62 billion by 2034, growing at a CAGR of around 6.1%. Rising prevalence of seasonal allergies, improved diagnostic awareness, and the increasing use of immunotherapy are the primary factors fueling market growth.

Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/71309

Key Market Drivers
• Higher incidence of birch pollen allergies in North America and Europe.
• Growing demand for allergen immunotherapy (sublingual & subcutaneous).
• Increased use of component-resolved diagnostics for precise allergen identification.
• Rising awareness of cross-reactive food allergies linked to birch pollen.

Challenges
• Seasonal variations impacting testing and treatment demand.
• Limited awareness in developing regions.
• High cost of long-term immunotherapy treatment.

Explore Full Report here:
https://exactitudeconsultancy.com/reports/71309/birch-allergy-market

Market Segmentation
By Treatment
• Allergen Immunotherapy (SCIT, SLIT)
• Antihistamines
• Nasal corticosteroids
• Other symptomatic treatments

By Diagnosis
• Skin prick testing
• IgE blood testing
• Component-resolved diagnostics

By End User
• Hospitals
• Allergy clinics
• Diagnostic laboratories
• Homecare (for SLIT therapies)

By Distribution Channel
• Hospital pharmacies
• Retail pharmacies
• Online pharmacies

Regional Snapshot
• Europe leads the market due to high birch pollen exposure and strong adoption of immunotherapy.
• North America shows steady demand with advanced diagnostics and awareness.
• Asia-Pacific is growing as allergy testing becomes more accessible and awareness increases.

Key Companies
ALK-Abelló, Stallergenes Greer, HAL Allergy, Torii Pharmaceutical, LETI Pharma, Thermo Fisher Scientific, Novartis.

Future Outlook
Growth will be driven by expanded immunotherapy usage, improved diagnostic precision, and rising global prevalence of pollen-induced allergic conditions. Personalized allergy treatment and preventive therapies are expected to shape the next decade.

This report is also available in the following languages : Japanese (バーチアレルギーマーケット), Korean (자작나무 알레르기 시장), Chinese (桦树过敏市场), French (Marché des allergies au bouleau), German (Birkenallergiemarkt), and Italian (Mercato delle allergie alla betulla), etc.

Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/71309

Our More Reports:

Chemotherapy Induced Febrile Neutropenia Market
https://exactitudeconsultancy.com/reports/71301/chemotherapy-induced-febrile-neutropenia-market

Disseminated Intravascular Coagulation Market
https://exactitudeconsultancy.com/reports/71303/disseminated-intravascular-coagulation-market

Adult-onset Still Disease Market
https://exactitudeconsultancy.com/reports/71305/adult-onset-still-disease-market

Axial Spondyloarthritis Market
https://exactitudeconsultancy.com/reports/71307/axial-spondyloarthritis-market

About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/

https://www.thehealthanalytics.com/

https://www.analytica.global/

https://www.marketintelligencedata.com/

https://www.marketinsightsreports.com/

https://exactitudeconsultancy.com/

Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com

This release was published on openPR.